Livingstone Health Holdings has reversed into earnings for the FY2025 ended March 31, 2025 of $557,000, compared to a net loss reported in the same period a year ago.
The group reported revenue for the FY2025 of $27.65 million, up 9% y-o-y.
Livingstone Health says that the reversal into earnings is a result of ongoing streamlining efforts, in which the group managed to lower its operating costs.
Employee benefits expenses reduced to $15.0 million, and other operating expenses reduced to S$4.9 million.
Due to improving accounts receivable collection as the group stepped up in chasing payments, the group recorded a net bad debt recovery of approximately $43,000 in FY2025 compared to a net impairment loss of financial assets of $0.6 million in FY2024.
Other operating income for the year came in at $0.8 million and another gain of about $58,000 due to the consolidation of Atlas Podiatry, its joint venture.
See also: Grand Venture Tech reports 1QFY2025 earnings of $2.6 mil, up 27.7% y-o-y
The group also recorded a higher net operating cash flow of $3.9 million compared to $0.9 million in the same period a year ago.
As at end March, net assets stood at $6.4 million, and cash and cash equivalents stood at $3 million. Bank borrowings decreased to $2 million as at end March due to repayments.
Shares in Livingstone closed flat at 2.3 cents on May 29.
